{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T08:11:13Z","timestamp":1778832673197,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273327"],"award-info":[{"award-number":["82273327"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.anndiagpath.2026.152638","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T08:53:23Z","timestamp":1773392003000},"page":"152638","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["SMARCA4-deficient thoracic malignancies with small cell lung cancer-like features: A clinicopathological and molecular study of a heterogeneous group"],"prefix":"10.1016","volume":"83","author":[{"given":"Jie-rong","family":"Ding","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue-guang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiu-yuan","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Man-yu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ru-song","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ru","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-xia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiu","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2026.152638_bb0005","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jtho.2021.11.003","article-title":"The 2021 WHO classification of lung tumors: impact of advances since 2015","volume":"17","author":"Nicholson","year":"2022","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.anndiagpath.2026.152638_bb0010","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41379-021-00943-2","article-title":"Lung neuroendocrine neoplasms: recent progress and persistent challenges","volume":"35","author":"Rekhtman","year":"2022","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2026.152638_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.216022","article-title":"SMARCA4: current status and future perspectives in non-small-cell lung cancer","volume":"554","author":"Tian","year":"2023","journal-title":"Cancer Lett"},{"key":"10.1016\/j.anndiagpath.2026.152638_bb0020","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jtho.2019.10.023","article-title":"SMARCA4-deficient thoracic sarcomatoid tumors represent primarily smoking-related undifferentiated carcinomas rather than primary thoracic sarcomas","volume":"15","author":"Rekhtman","year":"2020","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.anndiagpath.2026.152638_bb0025","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1158\/2159-8290.CD-22-0620","article-title":"Integrative analysis of a large real-world cohort of small cell lung cancer identifies distinct genetic subtypes and insights into histologic transformation","volume":"13","author":"Sivakumar","year":"2023","journal-title":"Cancer Discov"},{"key":"10.1016\/j.anndiagpath.2026.152638_bb0030","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.chest.2024.05.026","article-title":"The proposed ninth edition TNM classification of lung cancer","volume":"166","author":"Detterbeck","year":"2024","journal-title":"Chest"},{"key":"10.1016\/j.anndiagpath.2026.152638_bb0035","first-page":"881","article-title":"Linking p53 immunostaining to TP53 mutation status in patients with non-small cell lung cancer","volume":"57","author":"Kim","year":"2025","journal-title":"Pathology (Phila)"},{"key":"10.1016\/j.anndiagpath.2026.152638_bb0040","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jtho.2020.01.002","article-title":"Clinicopathologic characteristics of BRG1-deficient NSCLC","volume":"15","author":"Dagogo-Jack","year":"2020","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.anndiagpath.2026.152638_bb0045","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1158\/1078-0432.CCR-17-2310","article-title":"Investigating novel resistance mechanisms to third-generation EGFR tyrosine kinase inhibitor osimertinib in non\u2013small cell lung cancer patients","volume":"24","author":"Yang","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.anndiagpath.2026.152638_bb0050","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/ng.806","article-title":"A framework for variation discovery and genotyping using next-generation DNA sequencing data","volume":"43","author":"DePristo","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.anndiagpath.2026.152638_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217282","article-title":"SMARCA4 and SMARCA2 co-deficiency: an uncommon molecular signature defining a subset of rare, aggressive and undifferentiated malignancies associated with defective chromatin remodeling","volume":"605","author":"Field","year":"2024","journal-title":"Cancer Lett"},{"key":"10.1016\/j.anndiagpath.2026.152638_bb0060","article-title":"SMARCA4 controls state plasticity in small cell lung cancer through regulation of neuroendocrine transcription factors and REST splicing","volume":"17","author":"Redin","year":"2024","journal-title":"J Hematol OncolJ Hematol Oncol"},{"key":"10.1016\/j.anndiagpath.2026.152638_bb0065","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1177\/10668969211047982","article-title":"Expanding the immunophenotype spectrum of SMARCA4-deficient non-small cell lung carcinomas: a case series with neuroendocrine markers expression","volume":"30","author":"Mao","year":"2022","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2026.152638_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1538548","article-title":"Case report: three cases of lung large cell neuroendocrine carcinoma with clinicopathological features of SMARCA4 (BRG1) deficiency","volume":"15","author":"Zou","year":"2025","journal-title":"Front Oncol"},{"key":"10.1016\/j.anndiagpath.2026.152638_bb0075","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.5858\/arpa.2021-0001-OA","article-title":"SMARCA4\/BRG1-deficient sinonasal carcinoma","volume":"146","author":"Kakkar","year":"2022","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.anndiagpath.2026.152638_bb0080","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/PAS.0000000000001428","article-title":"SMARCA4-deficient sinonasal carcinoma: a series of 10 cases expanding the genetic spectrum of SWI\/SNF-driven sinonasal malignancies","volume":"44","author":"Agaimy","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2026.152638_bb0085","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s13023-024-03244-4","article-title":"Gastric SMARCA4-deficient undifferentiated tumor (SMARCA4-UT): a clinicopathological analysis of four rare cases","volume":"19","author":"Zhou","year":"2024","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.anndiagpath.2026.152638_bb0090","article-title":"Thoracic SMARCA4-deficient tumors: a clinicopathological analysis of 52 cases with SMARCA4-deficient non-small cell lung cancer and 20 cases with thoracic SMARCA4-deficient undifferentiated tumor","volume":"12","author":"Zhou","year":"2024","journal-title":"PeerJ"},{"key":"10.1016\/j.anndiagpath.2026.152638_bb0095","doi-asserted-by":"crossref","DOI":"10.1093\/oncolo\/oyaf266","article-title":"Clinicopathological and molecular characteristics and treatment outcomes of SMARCA4-deficient thoracic tumors: a comprehensive analysis","volume":"30","author":"Liu","year":"2025","journal-title":"Oncologist"},{"key":"10.1016\/j.anndiagpath.2026.152638_bb0100","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1158\/1078-0432.CCR-23-2360","article-title":"Molecular and pathologic characterization of YAP1-expressing small cell lung cancer cell lines leads to reclassification as SMARCA4-deficient malignancies","volume":"30","author":"Ng","year":"2024","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.anndiagpath.2026.152638_bb0105","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1158\/1078-0432.CCR-24-0227","article-title":"All that is small is not a small-cell carcinoma: thoracic SMARCA4-deficient undifferentiated tumors masquerading as SCLC","volume":"30","author":"Rekhtman","year":"2024","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.anndiagpath.2026.152638_bb0110","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1001\/jama.2025.0560","article-title":"Small cell lung cancer: a review","volume":"333","author":"Kim","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.anndiagpath.2026.152638_bb0115","first-page":"620","article-title":"Clinical insights into small cell lung cancer: tumor heterogeneity, diagnosis, therapy, and future directions","volume":"73","author":"Megyesfalvi","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.anndiagpath.2026.152638_bb0120","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1080\/10408363.2025.2493121","article-title":"New insight in early detection and precision medicine in small cell lung cancer: liquid biopsy as innovative clinical tool","volume":"62","author":"Santamaria","year":"2025","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.anndiagpath.2026.152638_bb0125","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12943-024-02012-z","article-title":"DLL3-guided therapies in small-cell lung cancer: from antibody-drug conjugate to precision immunotherapy and radioimmunotherapy","volume":"23","author":"Su","year":"2024","journal-title":"Mol Cancer"},{"key":"10.1016\/j.anndiagpath.2026.152638_bb0130","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1001\/jamaoncol.2022.5631","article-title":"Emerging strategies for the treatment of small cell lung cancer: a review","volume":"9","author":"Petty","year":"2023","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.anndiagpath.2026.152638_bb0135","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25063237","article-title":"Treatment of thoracic SMARCA4-deficient undifferentiated tumors: where we are and where we will go","volume":"25","author":"Longo","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.anndiagpath.2026.152638_bb0140","first-page":"OF1","article-title":"PRT3789 is a first-in-human SMARCA2-selective degrader that induces synthetic lethality in SMARCA4 -mutated cancers","author":"Hulse","year":"2025","journal-title":"Cancer Res"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913426000341?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913426000341?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T07:38:54Z","timestamp":1778830734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913426000341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":28,"alternative-id":["S1092913426000341"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2026.152638","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SMARCA4-deficient thoracic malignancies with small cell lung cancer-like features: A clinicopathological and molecular study of a heterogeneous group","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2026.152638","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152638"}}